Compugen Ltd. (CGEN)
NASDAQ: CGEN · IEX Real-Time Price · USD
1.760
-0.060 (-3.30%)
Jul 22, 2024, 10:09 AM EDT - Market open
Compugen Employees
Compugen had 68 employees as of December 31, 2023. The number of employees decreased by 1 or -1.45% compared to the previous year.
Employees
68
Change (1Y)
-1
Growth (1Y)
-1.45%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
158.02M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
TruBridge | 3,219 |
Repare Therapeutics | 179 |
Stereotaxis | 122 |
TriSalus Life Sciences | 112 |
Syros Pharmaceuticals | 68 |
Achieve Life Sciences | 22 |
INmune Bio | 17 |
Skye Bioscience | 11 |
CGEN News
- 5 weeks ago - Compugen to Present at Upcoming Antibody Industrial Symposium - PRNewsWire
- 7 weeks ago - Compugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig - PRNewsWire
- 2 months ago - Compugen Reports First Quarter 2024 Results - PRNewsWire
- 2 months ago - Compugen Publishes Paper in Cancer Immunology Research on Unique Biology of PVRIG and its Therapeutic Potential - PRNewsWire
- 2 months ago - Compugen Appoints David Silberman as Chief Financial Officer - PRNewsWire
- 2 months ago - Compugen to Release First Quarter 2024 Results on Monday, May 20, 2024 - PRNewsWire
- 3 months ago - Compugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024 - PRNewsWire
- 3 months ago - Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503 - PRNewsWire